EnGene Insider Buys Signal Confidence Ahead of 2026 BLA FilingEnGene insider buys 600k+ shares, signaling confidence before a 2026 BLA filing for Detalimogene, amid negative EPS and FDA‑focused strategy.ENGENE THERAPEUTICS INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 17/06/2026, 23:59 4 minutes to read
